Medivation
For-Profit Corporation General Stock
Medivation, Inc. was an American biopharmaceutical company focused on development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation was headquartered in San Francisco, California, beginning operations in December 2004 with the acquisition of Medivation Neurology, Inc. Its final CEO was David Hung.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
—
not enough monitored evidence
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
—
not enough monitored evidence
AI Adoption
—
not enough monitored evidence
Corporate Change Index
—
not enough monitored evidence
17 active sensors·0 observations·0 historical changes·0 structured events
Compare Medivation with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies